Health
Two coronavirus vaccines begin the last phase of testing: 30,000-person trials – The Washington Post
The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.
The vaccination marks a much-anticipated milestone: the official launch of the first in a series of large U.S. clinical trials that will each test experimental vaccines in 30,000 participants, half receiving the shot and half receiving a placebo. Pharmaceutical giant Pfizer also announced it was initiating a 30,000-person vaccine trial, at 120 sites globally.
We are participating today in the launching of a truly historic event in the history of vaccinology, Anthony S. Fauci, director of the Na…
-
General17 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General9 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General16 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General22 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat